Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer

Cancer Treat Rev. 2003 Oct;29(5):449-52. doi: 10.1016/s0305-7372(03)00167-1.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage*
  • Disease-Free Survival
  • Dose-Response Relationship, Drug
  • Doxorubicin / administration & dosage*
  • Drug Administration Schedule
  • Evidence-Based Medicine
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Mastectomy / methods
  • Middle Aged
  • Neoplasm Recurrence, Local / epidemiology*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Paclitaxel / administration & dosage*
  • Probability
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Substances

  • Doxorubicin
  • Cyclophosphamide
  • Paclitaxel